Jane Street Group LLC Grows Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

Jane Street Group LLC boosted its position in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 240.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,484 shares of the technology company's stock after acquiring an additional 39,915 shares during the quarter. Jane Street Group LLC owned 0.28% of Simulations Plus worth $1,575,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in SLP. Jones Financial Companies Lllp raised its holdings in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after acquiring an additional 427 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Simulations Plus during the fourth quarter worth approximately $39,000. Tower Research Capital LLC TRC raised its holdings in Simulations Plus by 42.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares in the last quarter. AlphaQuest LLC raised its holdings in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after purchasing an additional 2,243 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new stake in Simulations Plus during the fourth quarter worth approximately $86,000. Institutional investors and hedge funds own 78.08% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on SLP shares. KeyCorp raised their target price on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Two investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $50.00.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 19.40% of the company's stock.

Simulations Plus Stock Performance

Simulations Plus stock traded up $0.55 during trading hours on Friday, reaching $33.04. 353,098 shares of the stock were exchanged, compared to its average volume of 217,071. Simulations Plus, Inc. has a 52-week low of $23.01 and a 52-week high of $50.11. The stock has a market cap of $664.47 million, a P/E ratio of 82.60 and a beta of 1.10. The firm's 50 day moving average is $29.67 and its 200 day moving average is $30.39.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. During the same period in the previous year, the business posted $0.20 earnings per share. The business's revenue was up 22.5% compared to the same quarter last year. Equities research analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.